The Senate Health, Education, Labor and Pensions Committee introduces a bill to reauthorize FDAs user fee programs in addition to provisions to streng...
A Friends of Cancer Research-funded analysis shows a positive correlation between drugs receiving a breakthrough therapy designation for non-small cel...
Attorney Nancy Taylor asks FDA to take steps to increase the use of OTC external analgesics in pain management.
FDA says an Abbott recall of specific lots of its Dragonfly OpStar imaging catheter due to a potential loose marker band is Class 1.
Federal Register notice: FDA announces a 7/28-29 General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee meeting that will...
Federal Register notice: FDA seeks comments on an information collection extension entitled Postmarket Surveillance of Medical Devices 21 CFR Part 82...
FDA approves the ManaMed ManaSport Class 2 ultrasound therapy device for pain relief and soft-tissue injuries.
FDA grants fast track designation for Pfizers ervogastat/clesacostat combination drug being developed to treat non-alcoholic steatohepatitis.